OR WAIT null SECS
July 02, 2021
Vaccines define the path to putting the pandemic in the rear-view mirror.
Five therapeutic candidates for the treatment of COVID-19 are identified as promising by the European Commission.
June 02, 2021
GSK’s position is raising concerns as it continues working towards its separation of businesses.
Bio/pharmaceutical manufacturers have made a good first step toward global vaccination through pledging doses at no- to low-profit rates.
May 02, 2021
As face masks start to come off, bio/pharma’s COVID-19 battle goes on.
The world of bio/pharma has been celebrating its achievements across a variety of categories in the latest rounds of awards.
April 02, 2021
Smart, accurate, science-based messaging is needed to advance bio/pharma science.
COVID-19 has placed bio/pharma in the spotlight of global media, but away from vaccines there are other prospective pipeline treatments that will be worth watching.
March 02, 2021
Bio/pharma works hard today to change the calendar to tomorrow.
More work is needed to ensure the rising demand for cell and gene therapy manufacturing capacity and required skilled workforce can be met in Europe.